0001645113-20-000131.txt : 20200910
0001645113-20-000131.hdr.sgml : 20200910
20200910200850
ACCESSION NUMBER: 0001645113-20-000131
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200901
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cordova Ashley
CENTRAL INDEX KEY: 0001822014
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 201169697
MAIL ADDRESS:
STREET 1: 20 VALLEY STREAM PARKWAY,
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
3
1
wf-form3_159978291221889.xml
FORM 3
X0206
3
2020-09-01
0
0001645113
NovoCure Ltd
NVCR
0001822014
Cordova Ashley
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Financial Officer
Ordinary Shares
7348
D
Restricted Share Units
1465
D
Restricted Share Units
1006
D
Restricted Share Units
5314
D
Restricted Share Units
5405
D
Restricted Share Units
5904
D
Options to Buy Ordinary Shares
15.6
2025-04-22
Ordinary Shares
13840.0
D
Options to Buy Ordinary Shares
11.46
2026-02-24
Ordinary Shares
8936.0
D
Options to Buy Ordinary Shares
11.44
2026-07-27
Ordinary Shares
2480.0
D
Options to Buy Ordinary Shares
7.15
2027-02-21
Ordinary Shares
9752.0
D
Options to Buy Ordinary Shares
47.04
2029-03-21
Ordinary Shares
14595.0
D
Options to Buy Ordinary Shares
19.25
2021-07-26
2027-07-25
Ordinary Shares
7500.0
D
Options to Buy Ordinary Shares
21.5
2028-02-26
Ordinary Shares
16051.0
D
Options to Buy Ordinary Shares
32.02
2028-10-29
Ordinary Shares
8300.0
D
Options to Buy Ordinary Shares
69.37
2030-03-02
Ordinary Shares
10422.0
D
Options to Buy Ordinary Shares
84.68
2030-08-31
Ordinary Shares
11336.0
D
Represents restricted share units that are scheduled to vest on February 27, 2021, subject to the reporting person's continued employment through such date.
Represents restricted share units that are scheduled to vest in equal installments on each of October 30, 2020 and 2021, subject to the reporting person's continued employment through such dates.
Represents restricted share units that are scheduled to vest in equal installments on each of March 22, 2021 and 2022, subject to the reporting person's continued employment through such dates.
Represents restricted share units that are scheduled to vest in equal installments on each of March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates.
Represents restricted share units that are scheduled to vest in equal installments on each of September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates.
Currently exercisable.
Options to buy 9,752 ordinary shares, 2 shares of which are currently exercisable and the remainder vest on February 22, 2021.
Options to buy 14,595 ordinary shares, 3,649 shares of which are currently exercisable and the remaining 10,946 shares of which will vest and become exercisable in equal installments on each of March 22, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates.
Options to buy 16,051 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2021 and 2022, subject to the reporting person's continued employment through such dates.
Options to buy 8,300 ordinary shares will vest and become exercisable in equal installments on each of October 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates.
Options to buy 10,422 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
Options to buy 11,336 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova
2020-09-10